Larvol Delta - An-Openlabel-Study-to-Assess-the-Safety-Efficacy-and-Cellular-Kinetics-of-YTB323-in-Relapsing-Multiple-Sclerosis

rapcabtagene autoleucel (YTB323) - Novartis

http://clinicaltrials.gov/ct2/show/NCT06617793

Sep 3, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next